Åsa Johansson

Uppsala University

Scientific Lead for Precision Medicine at SciLifeLab

Key Publications
Time-resolved Mendelian randomization detects substantial variation in the detrimental effect of obesity throughout life
Science Advances, 2025
T2T-CHM13 improves read mapping and detection of clinically relevant genetic variation in the Swedish population
Genome Research, 2025
Oral contraceptive use increases bone density and reduces the risk of osteoporosis
European Journal of Epidemiology, 2025
Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare
Nature Medicine, 2025
Genomic and proteomic signatures highlight diverse pathways between obesity and type-2 diabetes
2025

Research Interests

Every fourth individual in Europe has ever been diagnosed with a common disease, such as cancer, asthma, diabetes, or myocardial infarction. The aim of our research is to determine genetic and lifestyle factors that influence human phenotypes, clinical variables, and risk of disease. We also evaluate how such factors can be used to predict, or even prevent, common diseases. The goal is to broaden our knowledge of disease pathophysiology, which is important for developing drugs to prevent, delay progression, or relieve symptoms of disease.

Group Members

Azimi, Tayebe
Deng, Yaqi
Ek, Weronica
Hadizadeh, Fatemeh
Johansson, Therese
Karlsson, Torgny
Koteci, Ardita
Lo Faro, Valeria
Mutie, Pascal
Rask-Andersen, Mathias
Schmitz, Daniel

Last updated: 2023-12-20

Content Responsible: David Gotthold(david.gotthold@scilifelab.se)